Literature DB >> 8827931

What is orbital pseudotumor?

I Mombaerts1, R Goldschmeding, R O Schlingemann, L Koornneef.   

Abstract

We have reviewed the literature in order to delineate the clinicopathologic definition of orbital pseudotumor, also called idiopathic nonspecific orbital inflammation. The clinical picture of orbital pseudotumor varies widely, with signs of mass effect, inflammation and/or infiltration. On computed tomography, orbital pseudotumor presents as a unilateral focal or diffuse mass. The histopathologic hallmark of orbital pseudotumor is a mixed inflammatory infiltrate with fibrosis of varying degree. Contrary to an old belief, orbital pseudotumor is not related to orbital reactive lymphoid hyperplasia (pseudolymphoma) and is not a lymphoid tumor. Atypical histopathologic findings of orbital pseudotumor include dominant sclerosis, granulomatous inflammation, vasculitis, and tissue eosinophilia. In the absence of systemic fibroinflammatory, granulomatous, and vasculitic disease, these atypical histopathologic patterns can be considered to represent subclasses of orbital pseudotumors rather then distinct entities. Clinical and prognostic characteristics of both histopathologically classical and atypical orbital pseudotumors appear to be heterogeneous. The etiology of orbital pseudotumor is unknown, but infection, autoimmune disorder, and aberrant wound healing have all been put forward as possibilities. In conclusion, orbital pseudotumor is one distinct disease albeit with many clinical and histopathologic guises.

Entities:  

Mesh:

Year:  1996        PMID: 8827931     DOI: 10.1016/s0039-6257(97)81996-0

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  36 in total

1.  Idiopathic sclerotic inflammation of the orbit with left optic nerve compression in a patient with multifocal fibrosclerosis.

Authors:  G J Schaffler; J Simbrunner; H Lechner; G Langmann; H Stammberger; A Beham; F Ebner
Journal:  AJNR Am J Neuroradiol       Date:  2000-01       Impact factor: 3.825

2.  Orbital inflammatory pseudotumor due to hypersensitivity vasculitis and mononeuritis multiplex in a patient with atypical, cANCA-positive Wegener's granulomatosis.

Authors:  Jörg Kaufmann; Eberhard Schulze; Ulrich Voigt; Jürgen Strobel; Gert Hein; Günter Stein
Journal:  Rheumatol Int       Date:  2003-04-17       Impact factor: 2.631

3.  Bilateral idiopathic orbital inflammatory syndrome with grossly elevated creatinine kinase levels.

Authors:  W H Chan; S Biswas; J Ashworth; I Hughes; V Sharma; I C Lloyd
Journal:  Eye (Lond)       Date:  2011-12-23       Impact factor: 3.775

4.  [Diagnosis and differential diagnosis of Graves' orbitopathy in MRI].

Authors:  D Daubner; S Spieth; K Engellandt; R von Kummer
Journal:  Radiologe       Date:  2012-06       Impact factor: 0.635

5.  Thyroid-associated orbitopathy.

Authors:  Adel H Alsuhaibani; Jeffrey A Nerad
Journal:  Semin Plast Surg       Date:  2007-02       Impact factor: 2.314

6.  Factors associated with multiple recurrences of nonspecific orbital inflammation aka orbital pseudotumor.

Authors:  Puneet S Braich; Robin K Kuriakose; Naveen S Khokhar; Jared C Donaldson; Timothy J McCulley
Journal:  Int Ophthalmol       Date:  2017-06-20       Impact factor: 2.031

7.  [Diseases of the lacrimal gland].

Authors:  N Fichter; M Schittkowski; R F Guthoff
Journal:  Ophthalmologe       Date:  2005-04       Impact factor: 1.059

Review 8.  Inflammatory pseudotumor of the cavernous sinus and skull base.

Authors:  Todd McCall; Daniel R Fassett; George Lyons; William T Couldwell
Journal:  Neurosurg Rev       Date:  2006-03-25       Impact factor: 3.042

9.  Unusual case of pancreatic inflammatory myofibroblastic tumor associated with spontaneous splenic rupture.

Authors:  Kamal S Hassan; Hector I Cohen; Fadi K Hassan; Shadi K Hassan
Journal:  World J Emerg Surg       Date:  2010-11-22       Impact factor: 5.469

Review 10.  Ocular myositis.

Authors:  Clare L Fraser; Simon E Skalicky; Avinash Gurbaxani; Peter McCluskey
Journal:  Curr Allergy Asthma Rep       Date:  2013-06       Impact factor: 4.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.